Documents
Application Sponsors
NDA 200738 | BAUSCH AND LOMB | |
Marketing Status
Application Products
001 | OINTMENT;OPHTHALMIC | 0.5% | 1 | LOTEMAX | LOTEPREDNOL ETABONATE |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2011-04-15 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-12-08 | STANDARD |
Submissions Property Types
CDER Filings
BAUSCH AND LOMB
cder:Array
(
[0] => Array
(
[ApplNo] => 200738
[companyName] => BAUSCH AND LOMB
[docInserts] => ["",""]
[products] => [{"drugName":"LOTEMAX","activeIngredients":"LOTEPREDNOL ETABONATE","strength":"0.5%","dosageForm":"OINTMENT;OPHTHALMIC","marketingStatus":"Prescription","te":"None","rld":"Yes","rs":"Yes"}]
[labels] => [{"actionDate":"04\/15\/2011","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/200738s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"04\/15\/2011","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/200738s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2011\\\/200738s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2011\\\/200738_lotemax_toc.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2011\\\/200738Orig1s000SumR.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2011-04-15
)
)